Sugi Predict

Sugi Predict / Compounds / SCHEMBL31347347

SCHEMBL31347347

SCHEMBL31347347

C[C@@H](O)[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)C(C)(C)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O

nearest known ligand 0.51

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ GLP1R P43220 6/20 0.51
▸ OPRM1 P35372 3/20 0.48
▸ OPRD1 P41143 3/20 0.48
▸ OPRK1 P41145 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30721572 0.91 GLP1R (0.61) GLP1ROPRM1OPRD1OPRK1
SCHEMBL29436306 0.88 OPRM1 (0.54) OPRM1OPRD1OPRK1
SCHEMBL30721545 0.87 GLP1R (0.58) GLP1ROPRM1OPRD1OPRK1
SCHEMBL29858376 0.86 NAALAD2 (0.47) GLP1ROPRM1OPRD1
SCHEMBL31265496 0.86 GLP1R (0.66) GLP1ROPRM1OPRD1OPRK1
SCHEMBL31759060 0.84 GLP1R (0.60) GLP1ROPRM1OPRD1OPRK1
SCHEMBL30278876 0.84 GLP1R (0.60) GLP1R
SCHEMBL29674783 0.83 OPRM1 (0.53) OPRM1OPRD1OPRK1
SCHEMBL30637757 0.83 GLP1R (0.53) GLP1ROPRM1OPRD1OPRK1
SCHEMBL31256795 0.83 OPRM1 (0.57) GLP1ROPRM1OPRD1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4724472-A2 GLP-1/GIP DUAL, GLP-1/GCG DUAL AND GLP-1/GIP/GCG TRIPLE RECEPTOR AGONISTS Sun Pharmaceutical Industries Limited (IN) 2026-04-15 — — EP claimed
WO-2024252367-A2 NOVEL GLP-1/GIP DUAL AND GLP-1/GCG DUAL RECEPTOR AGONISTS SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) 2024-12-12 — — WO claimed
EP-4724472-A2 GLP-1/GIP DUAL, GLP-1/GCG DUAL AND GLP-1/GIP/GCG TRIPLE RECEPTOR AGONISTS Sun Pharmaceutical Industries Limited (IN) 2026-04-15 — — EP disclosed
WO-2024252367-A2 NOVEL GLP-1/GIP DUAL AND GLP-1/GCG DUAL RECEPTOR AGONISTS SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) 2024-12-12 — — WO disclosed
Send feedback